Poland· PL-100376430

Oviderm

A other emollients and protectives product containing propylenglycolum, registered in Poland by Reig Jofre Sp. z o.o.. The same ATC class is registered in 7 of our 19 countries.

ATC D02AX

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedOvidermATCD02AXREGISTER NO.PL-100376430PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Propylenglycolum is registered in 7 of 19 countries.

Countries holding a registration under ATC D02AX (other emollients and protectives), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 5 of them publish a price we can compare per daily dose

Propylenglycolum · ATC D02AX

7 / 19 countries

  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Propylenglycolum
Manufacturer
Reig Jofre Sp. z o.o.
Country
Poland (PL)
ATC code
D02AX
ATC class
Other emollients and protectives
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909991340063
  • gtin
    05909991340056

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Propylenglycolum in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All propylenglycolum products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Germany · Propylenglycol Smartpractice Europe
  • Finland · Oviderm
  • United Kingdom (Northern Ireland) · Methadose
  • Iceland · Oviderm
  • Norway · Oviderm
  • Sweden · Oviderm, Propyderm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e718838f-2ff0-4e9b-9616-85086e63828d
GET /v1/drugs/e718838f-2ff0-4e9b-9616-85086e63828d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Krem",
  "source": "urpl",
  "strength": "250 mg/g",
  "packaging": "05909991340056 ¦ OTC ¦ 123752\n1 tuba 100 g\n05909991340063 ¦ OTC ¦ 123753\n1 pojemnik 500 g",
  "substance": "Propylene glycol 250 mg/g",
  "common_name": "Propylenglycolum",
  "pl_product_id": "100376430",
  "pozwolenie_nr": "24182",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

See everything about propylenglycolum.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.